TG Therapeutics director plans sale of 5,000 shares

Director Laurence N. Charney filed a Rule 144 notice to potentially sell 5,000 TGTX common shares acquired via restricted stock vesting.

Rhea-AI Filing Summary

TG THERAPEUTICS, INC. (TGTX) had a notice filed for a proposed sale of its common stock under Rule 144 by director Laurence N. Charney. The notice covers 5,000 shares of common stock, originally acquired from the issuer on January 1, 2023 through Restricted Stock Vesting as compensation.

The shares are held in an account at Fidelity Brokerage Services LLC and are proposed for sale on NASDAQ. The aggregate market value of the shares referenced in the notice is listed as $274,794.08. The form is signed by Daniel Tucci as a duly authorized representative of Fidelity, acting as attorney-in-fact for Laurence Charney.

Key Figures

Shares proposed for sale: 5,000 shares Aggregate market value referenced: $274,794.08 Acquisition date of shares: January 1, 2023 +2 more

5 metrics

Shares proposed for sale 5,000 shares Common stock of TG THERAPEUTICS, INC. covered by the Rule 144 notice

Aggregate market value referenced $274,794.08 Value listed for the 5,000 shares in the Form 144 securities information section

Acquisition date of shares January 1, 2023 Date the 5,000 shares were acquired via Restricted Stock Vesting as compensation

Planned trading market NASDAQ Exchange identified for the proposed sale of the common stock

CUSIP / identifier 153069053 Identifier associated with the common stock in the securities information section

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact, Compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 01/01/2023 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

Compensation financial

"5000 | 01/01/2023 | Compensation"

FAQ

What does the Form 144 filing for TGTX disclose about the planned stock sale?

The Form 144 notice discloses a proposed sale of 5,000 shares of TG THERAPEUTICS, INC. common stock by director Laurence N. Charney, with the shares held at Fidelity and intended for sale on NASDAQ under Rule 144.

How many TGTX shares is director Laurence N. Charney planning to sell under this Form 144?

The notice covers a proposed sale of 5,000 shares of TG THERAPEUTICS, INC. common stock. These shares were previously acquired through restricted stock vesting and are now the subject of this Rule 144 sale notice.

When and how were the TGTX shares in this Form 144 acquired?

The 5,000 TGTX shares were acquired on January 1, 2023 via Restricted Stock Vesting from TG THERAPEUTICS, INC. The filing describes the nature of acquisition as Compensation from the issuer.

What value is associated with the TGTX shares in this Form 144 filing?

The Form 144 lists an aggregate market value of $274,794.08 for the 5,000 shares of TG THERAPEUTICS, INC. common stock referenced in the notice, in connection with the proposed Rule 144 sale.

Who is executing the Rule 144 sale for the TGTX shares and in what capacity?

The notice identifies Fidelity Brokerage Services LLC as the broker. It is signed by Daniel Tucci as a duly authorized representative of Fidelity, acting as attorney-in-fact for Laurence Charney in connection with the proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:47 PM Accepted by SEC EDGAR 09/10/2026 - 04:46 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001407451
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TG THERAPEUTICS, INC.
SEC File Number	001-32639
Address of Issuer	2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NEW YORK 10014
Phone	(212) 554-4484
Name of Person for Whose Account the Securities are To Be Sold	Charney Laurence N
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5000	274794.08	153069053	09/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2023	Restricted Stock Vesting	Issuer			5000	01/01/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Laurence Charney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)